Delivery Order SPE2DB20D3103-SPE2DB25FP8T7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $14,267.84 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $11,377.52 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 18, 2025, with completion scheduled for September 19, 2025. This firm fixed price, non-set-aside contract reflects a routine pharmaceutical procurement supporting federal medical supply requirements. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the...
- The Defense Logistics Agency awarded a delivery order valued at $20,764.92 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitive, non-set-aside contract employs firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a $19,435.63 delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $13,965.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count package. Issued on September 18, 2025, with an ultimate completion date of September 19, 2025, this firm fixed-price delivery order represents a non-competitive award under an existing contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $4,158.66 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on August 21, 2025, with completion anticipated by August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,297.06 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on June 27, 2025, with completion scheduled for June 30, 2025. This firm fixed price, competitively awarded delivery order represents a pharmaceutical supply requirement without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the place of...
- The Defense Logistics Agency awarded a delivery order valued at $36,477.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $10,390.57 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on August 18, 2025, with completion scheduled for August 19, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $15,710.91 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed price contract. The award was made on July 14, 2025, with an ultimate completion date of July 15, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8T7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,457.37 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on August 14, 2025, with completion expected by August 15, 2025. This firm fixed price contract represents a non-set-aside competitive award, with performance conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfilled this order under its existing contractual relationship with the Defense Logistics Agency. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The Jardiance order fulfills ongoing pharmaceutical needs within the Defense Health Agency and broader military healthcare systems, demonstrating the vendor's role as a primary supplier of critical diabetes and endocrine medications to federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 8/14/25 |